Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
The Journal of Experimental Biology
|
March 6, 2007
Characterization of very-low density lipoprotein particle diameter dynamics in relation to egg production in a passerine bird
Katrina G Salvante, Gina Lin, Rosemary L Walzem, et al.
Experimental Brain Research
|
January 30, 2019
Shared right-hemispheric representations of sensorimotor goals in dynamic task environments
Ada Le, Francis Benjamin Wall, Gina Lin, et al.
Malaria Journal
|
November 28, 2015
Summary of anti-malarial prophylactic efficacy of tafenoquine from three placebo-controlled studies of residents of malaria-endemic countries
Geoffrey S Dow, Jun Liu, Gina Lin, et al.
Vaccine
|
July 27, 2011
Inferior quantitative and qualitative immune responses to pneumococcal conjugate vaccine in infants with nasopharyngeal colonization by Streptococcus pneumoniae during the primary series of immunization
Shabir A Madhi, Avy Violari, Keith P Klugman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 18, 2020
Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (TDF) Versus Efavirenz/Emtricitabine/TDF in Treatment-naive Adults With Human Immunodeficiency Virus Type 1 Infection: Week 96 Results of the Randomized, Double-blind, Phase 3 DRIVE-AHEAD Noninferiority Trial
Chloe Orkin, Kathleen E Squires, Jean-Michel Molina, et al.
Antimicrobial Agents and Chemotherapy
|
April 26, 2022
Exposure-Efficacy Analyses Support Optimal Dosing Regimens of Ceftolozane/Tazobactam in Participants with Hospital-Acquired/Ventilator-Associated Bacterial Pneumonia in ASPECT-NP
Wei Gao, Julie Passarell, Yogesh T Patel, et al.
Infectious Diseases (London, England)
|
September 6, 2025
Pooled data from phase 3 clinical trials comparing the clinical activity of ceftolozane/tazobactam versus meropenem for the treatment of complicated intra-abdominal infections
Zhiqiang Li, Yue Kang, Hongqiang Gao, et al.
The Lancet. Infectious Diseases
|
September 30, 2019
Ceftolozane-tazobactam versus meropenem for treatment of nosocomial pneumonia (ASPECT-NP): a randomised, controlled, double-blind, phase 3, non-inferiority trial
Marin H Kollef, Martin Nováček, Ülo Kivistik, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 6, 2018
Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate is Non-inferior to Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate in Treatment-naive Adults With Human Immunodeficiency Virus-1 Infection: Week 48 Results of the DRIVE-AHEAD Trial
Chloe Orkin, Kathleen E Squires, Jean-Michel Molina, et al.
Cell Death and Differentiation
|
June 8, 2026
A PML1-CCL5-PI3K/MAPK feedback loop governs survival of endocrine-resistant breast cancer cells
Han Wang, Zixi Yun, Yuan Cao, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
The Journal of Experimental Biology
|
March 6, 2007
Characterization of very-low density lipoprotein particle diameter dynamics in relation to egg production in a passerine bird
Katrina G Salvante, Gina Lin, Rosemary L Walzem, et al.
Experimental Brain Research
|
January 30, 2019
Shared right-hemispheric representations of sensorimotor goals in dynamic task environments
Ada Le, Francis Benjamin Wall, Gina Lin, et al.
Malaria Journal
|
November 28, 2015
Summary of anti-malarial prophylactic efficacy of tafenoquine from three placebo-controlled studies of residents of malaria-endemic countries
Geoffrey S Dow, Jun Liu, Gina Lin, et al.
Vaccine
|
July 27, 2011
Inferior quantitative and qualitative immune responses to pneumococcal conjugate vaccine in infants with nasopharyngeal colonization by Streptococcus pneumoniae during the primary series of immunization
Shabir A Madhi, Avy Violari, Keith P Klugman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 18, 2020
Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (TDF) Versus Efavirenz/Emtricitabine/TDF in Treatment-naive Adults With Human Immunodeficiency Virus Type 1 Infection: Week 96 Results of the Randomized, Double-blind, Phase 3 DRIVE-AHEAD Noninferiority Trial
Chloe Orkin, Kathleen E Squires, Jean-Michel Molina, et al.
Antimicrobial Agents and Chemotherapy
|
April 26, 2022
Exposure-Efficacy Analyses Support Optimal Dosing Regimens of Ceftolozane/Tazobactam in Participants with Hospital-Acquired/Ventilator-Associated Bacterial Pneumonia in ASPECT-NP
Wei Gao, Julie Passarell, Yogesh T Patel, et al.
Infectious Diseases (London, England)
|
September 6, 2025
Pooled data from phase 3 clinical trials comparing the clinical activity of ceftolozane/tazobactam versus meropenem for the treatment of complicated intra-abdominal infections
Zhiqiang Li, Yue Kang, Hongqiang Gao, et al.
The Lancet. Infectious Diseases
|
September 30, 2019
Ceftolozane-tazobactam versus meropenem for treatment of nosocomial pneumonia (ASPECT-NP): a randomised, controlled, double-blind, phase 3, non-inferiority trial
Marin H Kollef, Martin Nováček, Ülo Kivistik, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 6, 2018
Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate is Non-inferior to Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate in Treatment-naive Adults With Human Immunodeficiency Virus-1 Infection: Week 48 Results of the DRIVE-AHEAD Trial
Chloe Orkin, Kathleen E Squires, Jean-Michel Molina, et al.
Cell Death and Differentiation
|
June 8, 2026
A PML1-CCL5-PI3K/MAPK feedback loop governs survival of endocrine-resistant breast cancer cells
Han Wang, Zixi Yun, Yuan Cao, et al.
Page
of 2